Table 4.
The number and percent of resistant strains of Gram-negative uropathogens among pediatric patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia, 2014.
| Bacteria isolated | Total no. | Antimicrobial agents tested | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CIP | CXM | GN | NA | SXT | F | AMP | C | NOR | CTX | CAZ | ||
| No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | No. (%) | ||
| E. coli | 28 | 6 (21.4) | 9 (32.1) | 8 (28.6) | 9 (32.1) | 19 (67.9) | 5 (17.9) | 11 (39.3) | 8 (28.6) | 7 (25.0) | 9 (32.1) | 9 (32.1) |
| Klebsiella spp. | 17 | 5 (29.4) | 15 (88.2) | 14 (82.4) | 9 (52.9) | 15 (88.2) | 5 (29.4) | 12 (70.6) | 10 (58.8) | 6 (35.3) | 15 (88.2) | 15 (88.2) |
| Acinetobacter spp. | 1 | 0 | 0 | 1 (100) | 1 (100) | 1 (100) | 0 | 1 (100) | 0 | 0 | 0 | 0 |
| Proteus spp. | 3 | 0 | 0 | 0 | 0 | 0 | 3 (100) | 0 | 0 | 0 | 0 | 0 |
| Total | 49 | 11 (22.5) | 24 (48.9) | 23 (46.9) | 19 (38.7) | 35 (71.4) | 13 (26.5) | 24 (48.9) | 18 (36.7) | 13 (26.5) | 24 (48.9) | 24 (48.9) |
AMP: augmentin (30 μg); NOR: norfloxacin (30 μg); GN: gentamicin (30 μg); CIP: ciprofloxacin (5 μg); NA: nalidixic acid (30 μg); F: nitrofurantoin (30 μg); CAZ: ceftazidime (30 μg); CTX: cefotaxim (30 μg); C: chloramphenicol (30 μg); SXT: trimethoprim-sulfamethoxazole (1.25/23.75 μg); CXM: cefuroxime (30 μg).